Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis

Recruiting Phase 4 Interventional Study
Endocarditis Infective
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 4
Study type
Interventional
Purpose
Treatment
Participants needed
360 (estimated)
Sponsor
Fundacion Clinic per a la Recerca Biomédica · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Non-inferiority trial to determine whether partial oral treatment is non-inferior to OPAT(Outpatient parenteral therapy) in patients diagnosed with infective endocarditis

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Left-sided native or prosthetic infective endocarditis based on the modified Duke criteria infected with one of the following nonresistant microorganisms: Non-resistant streptococci and other gram positive cocci,e.g., Granulicatella and Abiotrophia; Enterococcus faecalis; Stap…
Contacts

Anna Cruceta

+34 932275400

acruceta@clinic.cat

CONTACT

Laura Burunat

+34 932275400

burunat@clinic.cat

CONTACT